Organovo Holdings Inc

Company Profile

Organovo Holdings Inc had its IPO on 2012-02-14 under the ticker symbol ONVO.

The company operates in the Healthcare sector and Biotechnology industry. Organovo Holdings Inc has a staff strength of 23 employees.

Stock update

Shares of Organovo Holdings Inc opened at $1.05 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.05 - $1.08, and closed at $1.07.

This is a +0.94% increase from the previous day's closing price.

A total volume of 12,287 shares were traded at the close of the day’s session.

In the last one week, shares of Organovo Holdings Inc have slipped by -4.46%.

Organovo Holdings Inc's Key Ratios

Organovo Holdings Inc has a market cap of $9.24 million, indicating a price to book ratio of 0.6063 and a price to sales ratio of 9.836.

In the last 12-months Organovo Holdings Inc’s revenue was $445000 with a gross profit of $-8515000 and an EBITDA of $-18377000. The EBITDA ratio measures Organovo Holdings Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Organovo Holdings Inc’s operating margin was -4199.33% while its return on assets stood at -51.56% with a return of equity of -91.67%.

In Q2, Organovo Holdings Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 89.2%.

Organovo Holdings Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-2.15 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Organovo Holdings Inc’s profitability.

Organovo Holdings Inc stock is trading at a EV to sales ratio of 246.2131 and a EV to EBITDA ratio of 0.5648. Its price to sales ratio in the trailing 12-months stood at 9.836.

Organovo Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$20.31 million

Total Liabilities

$3.67 million

Operating Cash Flow

$0

Capital Expenditure

$162000

Dividend Payout Ratio

0%

Organovo Holdings Inc ended 2024 with $20.31 million in total assets and $0 in total liabilities. Its intangible assets were valued at $20.31 million while shareholder equity stood at $15.33 million.

Organovo Holdings Inc ended 2024 with $0 in deferred long-term liabilities, $3.67 million in other current liabilities, 9000.00 in common stock, $-324998000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $15.30 million and cash and short-term investments were $16.01 million. The company’s total short-term debt was $492,000 while long-term debt stood at $0.

Organovo Holdings Inc’s total current assets stands at $17.05 million while long-term investments were $0 and short-term investments were $706000.00. Its net receivables were $152000.00 compared to accounts payable of $331000.00 and inventory worth $0.

In 2024, Organovo Holdings Inc's operating cash flow was $0 while its capital expenditure stood at $162000.

Comparatively, Organovo Holdings Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$1.07

52-Week High

$3.4

52-Week Low

$1

Analyst Target Price

$

Organovo Holdings Inc stock is currently trading at $1.07 per share. It touched a 52-week high of $3.4 and a 52-week low of $3.4. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $1.51 and 200-day moving average was $1.78 The short ratio stood at 14.22 indicating a short percent outstanding of 0%.

Around 98.5% of the company’s stock are held by insiders while 922.1% are held by institutions.